Exclusive

Publication

Byline

Location

US Patent Issued to Aragon Pharmaceuticals on Sept. 29 for "Anticancer compositions" (Belgian, American Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,230, issued on Sept. 29, was assigned to Aragon Pharmaceuticals Inc. (Horsham, Pa.). "Anticancer compositions" was invented by Johny Berte... Read More


US Patent Issued to Vima Therapeutics on Sept. 29 for "Therapeutic methods and compositions for treating movement disorders" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,231, issued on Sept. 29, was assigned to Vima Therapeutics Inc. (Cambridge, Mass.). "Therapeutic methods and compositions for treating mov... Read More


US Patent Issued to NOBELPHARMA on Sept. 29 for "Patch for alleviating or treating symptoms of neurodegenerative disease" (Japanese Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,232, issued on Sept. 29, was assigned to NOBELPHARMA Co. LTD. (Tokyo). "Patch for alleviating or treating symptoms of neurodegenerative di... Read More


US Patent Issued to SQUARE POWER on Sept. 29 for "Rebamipide for use in prevention and/or treatment of arterial stiffness" (Czech Inventor)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,233, issued on Sept. 29, was assigned to SQUARE POWER LTD. (London). "Rebamipide for use in prevention and/or treatment of arterial stiffn... Read More


US Patent Issued to NEURODAWN PHARMACEUTICAL on Sept. 29 for "Use of composition containing cilostazol in cerebrovascular diseases" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,234, issued on Sept. 29, was assigned to NEURODAWN PHARMACEUTICAL Co. LTD. (Nanjing, China). "Use of composition containing cilostazol in ... Read More


US Patent Issued to BIOBINA on Sept. 29 for "Use of dextromethorphan in combination with CYP2D6 and CYP3A4 enzyme inhibitors for the treatment of pain" (New York Inventor)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,235, issued on Sept. 29, was assigned to BIOBINA LLC (New York). "Use of dextromethorphan in combination with CYP2D6 and CYP3A4 enzyme inh... Read More


US Patent Issued to The Trustees of the University of Pennsylvania on Sept. 29 for "Quinine and its use to generate innate immune response" (Pennsylvania Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,236, issued on Sept. 29, was assigned to The Trustees of the University of Pennsylvania (Philadelphia). "Quinine and its use to generate i... Read More


US Patent Issued to Alkermes Pharma Ireland on Sept. 29 for "Crystallization process of aripiprazole derivatives in extended release formulations for treatment of schizophrenia" (Ohio, Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,237, issued on Sept. 29, was assigned to Alkermes Pharma Ireland Ltd. (Dublin). "Crystallization process of aripiprazole derivatives in ex... Read More


US Patent Issued to C4 THERAPEUTICS on Sept. 29 for "Selected compounds for targeted degradation of BRD9" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,238, issued on Sept. 29, was assigned to C4 THERAPEUTICS INC. (Watertown, Mass.). "Selected compounds for targeted degradation of BRD9" wa... Read More


US Patent Issued to United States Government As Represented By The Department of Veterans Affairs on Sept. 29 for "Compositions and methods comprising endothelin a receptor antagonists androgen therapies" (Michigan Inventor)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,239, issued on Sept. 29, was assigned to United States Government As Represented By The Department of Veterans Affairs (Washington). "Comp... Read More